Taiwanese are SOON to get COVID-19 shots, so medical personnel, government officials and the public should consider the finer points of vaccination information and scheduling. Accurate facts can be found, but they are frequently published next to false rumors, even in news outlets viewed as trustworthy.
EU news media have been reporting on adverse reactions and side effects experienced by medical personnel who received the vaccine developed by the University of Oxford and AstraZeneca.
German magazine Der Spiegel ran the headline: “The vaccine that nobody wants: Fears of AstraZeneca could have dangerous consequences.” The headline is misleading because it emphasizes some people’s fears, when a closer look shows them to be unfounded.
Among the three most commonly used COVID-19 vaccines, the Oxford-AstraZeneca vaccine has been administered to the largest number of people in the greatest number of countries, which underscores the amplification effect of myths, misinformation, complaints and resistance by a small number of medical personnel.
The Central Epidemic Command Center (CECC) has compiled data from the WHO on the frequency of side effects following injections of the Oxford-AstraZeneca, Pfizer-BioNTech and Moderna vaccines.
The most frequent side effect was pain at the injection site, followed by fatigue, headache and muscle soreness. The least frequent side effects included physiological and clinical symptoms, such as chills, joint pain and fevers of up to 38°C.
These symptoms have been reported at much lower frequencies for the Oxford-AstraZeneca vaccine than the other two vaccines — in the language of science, the differences are statistically significant.
The Oxford-AstraZeneca vaccine has two other advantages: It is the cheapest of the three, and it is easier to transport and store (between 2°C and 8°C in regular refrigerators, compared with minus-25°C to minus-15°C in special freezers).
The Oxford-AstraZeneca vaccine can be quickly shipped to international medical institutions using transportation equipment available in many countries. These advantages explain in great part the preference for the vaccine and its broader use.
People need to be wary when seeing headlines like the one in the German news magazine. The number of reported side effects for the Oxford-AstraZeneca vaccine is higher because more people have been vaccinated with it, but its rate of side effects is much lower than the Pfizer-BioNTech and Moderna vaccines.
The complaints of the earliest vaccinated medical personnel attracted a lot of media attention and dominated the news cycle for several days, which generated a disproportionately negative impression followed by excessive resistance.
The incorrect amplification of these negative impressions could detract from the CECC’s vaccination plan, which is based on a thorough review of the available evidence.
The media, as well as the public health units of the central and local governments, have the responsibility of clarifying and explaining information about COVID-19 vaccination. That includes accurately citing sources and explaining the difference between concepts, such as numbers and rates.
The public deserves to have access to reports on the side effects of the COVID-19 vaccines, but news and public health sources must go out of their way to provide the latest data and analyses.
Huang Chung-yuan is a professor in Chang Gung University’s Graduate Institute of Computer Science and Information Engineering.
Could Asia be on the verge of a new wave of nuclear proliferation? A look back at the early history of the North Atlantic Treaty Organization (NATO), which recently celebrated its 75th anniversary, illuminates some reasons for concern in the Indo-Pacific today. US Secretary of Defense Lloyd Austin recently described NATO as “the most powerful and successful alliance in history,” but the organization’s early years were not without challenges. At its inception, the signing of the North Atlantic Treaty marked a sea change in American strategic thinking. The United States had been intent on withdrawing from Europe in the years following
My wife and I spent the week in the interior of Taiwan where Shuyuan spent her childhood. In that town there is a street that functions as an open farmer’s market. Walk along that street, as Shuyuan did yesterday, and it is next to impossible to come home empty-handed. Some mangoes that looked vaguely like others we had seen around here ended up on our table. Shuyuan told how she had bought them from a little old farmer woman from the countryside who said the mangoes were from a very old tree she had on her property. The big surprise
The issue of China’s overcapacity has drawn greater global attention recently, with US Secretary of the Treasury Janet Yellen urging Beijing to address its excess production in key industries during her visit to China last week. Meanwhile in Brussels, European Commission President Ursula von der Leyen last week said that Europe must have a tough talk with China on its perceived overcapacity and unfair trade practices. The remarks by Yellen and Von der Leyen come as China’s economy is undergoing a painful transition. Beijing is trying to steer the world’s second-largest economy out of a COVID-19 slump, the property crisis and
Former president Ma Ying-jeou’s (馬英九) trip to China provides a pertinent reminder of why Taiwanese protested so vociferously against attempts to force through the cross-strait service trade agreement in 2014 and why, since Ma’s presidential election win in 2012, they have not voted in another Chinese Nationalist Party (KMT) candidate. While the nation narrowly avoided tragedy — the treaty would have put Taiwan on the path toward the demobilization of its democracy, which Courtney Donovan Smith wrote about in the Taipei Times in “With the Sunflower movement Taiwan dodged a bullet” — Ma’s political swansong in China, which included fawning dithyrambs